[Fibrosis in chronic hepatitis C infection: mechanisms and cofactors].
Bedossa
Pierre
P
Service d'Anatomie Pathologique, CNRS ESA8067, Hôpital de Bicêtre, Le Kremlin-Bicêtre.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000437:Alcoholism / Q000150:complications; D000998:Antiviral Agents / Q000627:therapeutic use; D001706:Biopsy; D002648:Child; D002921:Cicatrix / Q000473:pathology; D004797:Enzyme-Linked Immunosorbent Assay; D005234:Fatty Liver / Q000473:pathology; D005260:Female; D015658:HIV Infections / Q000150:complications; D006432:Hemochromatosis / Q000150:complications; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D007249:Inflammation; D015227:Lipid Peroxidation; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D008297:Male; D009336:Necrosis; D010641:Phenotype; D012307:Risk Factors; D012737:Sex Factors; D016212:Transforming Growth Factor beta / Q000032:analysis / Q000502:physiology; D024502:alpha-Tocopherol / Q000627:therapeutic use
D000998:Antiviral Agents; D016212:Transforming Growth Factor beta; D024502:alpha-Tocopherol